Key regions: Australia, Germany, United Kingdom, United States, France
The market for immunosuppressants in Kuwait has been growing steadily in recent years, driven by a combination of factors such as increasing demand for organ transplants, rising prevalence of autoimmune diseases, and a growing elderly population.
Customer preferences: Patients in Kuwait who require immunosuppressants generally prefer branded drugs over generics due to concerns about quality and efficacy. Additionally, many patients prefer to purchase their medications from pharmacies located within hospitals or clinics where they receive treatment, rather than from standalone pharmacies.
Trends in the market: The demand for immunosuppressants in Kuwait has been rising steadily due to an increasing number of organ transplants being performed in the country. In addition, the prevalence of autoimmune diseases such as rheumatoid arthritis and lupus has been on the rise, which has also contributed to the growth of the market. The government of Kuwait has been taking steps to improve access to healthcare services and medications, which has also helped to boost demand for immunosuppressants.
Local special circumstances: Kuwait has a relatively small population, which means that the market for immunosuppressants is also relatively small. However, the country has a high prevalence of certain medical conditions that require immunosuppressant therapy, such as diabetes and kidney disease. Additionally, the government provides free healthcare services to citizens and heavily subsidizes the cost of medications, which has helped to make immunosuppressants more affordable for patients.
Underlying macroeconomic factors: The economy of Kuwait is heavily dependent on the oil sector, which has been impacted by fluctuations in global oil prices in recent years. However, the government has been investing in diversifying the economy and developing other sectors such as healthcare. This has helped to create a favorable environment for the growth of the immunosuppressants market in Kuwait. Additionally, the country has a growing elderly population, which is expected to drive demand for immunosuppressants in the coming years.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
